Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists

Biochemical Pharmacology

Volumn 56, Issue 5, 1998, Pages 553-559

  Ebert, B ^a   Thorkildsen, C ^a   Andersen, S ^a   Christrup, L L ^a   Hjeds, H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

A29; Dextropropoxyphene; Fentanyl; Ketobemidone; Methadone; NMDA; Pain

Indexed keywords

DEXTROPROPOXYPHENE; FENTANYL; KETOBEMIDONE; METHADONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE;

DRUG ACTIVITY; DRUG MECHANISM; HUMAN; PAIN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0031671625     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00088-4     Document Type: Article

References (53)

1. H.W.D. Matthes R. Maldonado F. Simonin O. Valverde S. Slowe I. Kitchen K. Befort A. Dierich M. Le Meur P. Dollé E. Tzavara J. Hanoune B.P. Roques B.L. Kieffer Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene Nature 383 1996 819 823
2. F.F. Matos H. Rollema Y.O. Taiwo J.D. Levine A.I. Basbaum Relationship between analgesia and extracellular morphine in brain and spinal cord in awake rats Brain Res 693 1995 187 195
3. G. D’Honneur A. Gilton P. Sandouk J.M. Scherrmann P. Duvaldestin Plasma and cerebrospinal fluid concentrations of morphine and morphine glucoronides after oral morphine. The influence of renal failure Anesthiology 81 1994 87 93
4. R.G. Hill T.E. Salt C.M. Pepper A comparison of the effectiveness of intravenous morphine at attenuating the nociceptive responses of medullary dorsal horn and thalamic neurones Life Sci 31 1982 2331 2334
5. A.H. Dickenson Neurophysiology of opioid poorly responsive pain Cancer Surv 21 1994 5 16
6. A.W. Duggan R.A. North Electrophysiology of opiates Pharmacol Rev 35 1984 219 281
7. J. McFadzean The ionic mechanisms underlying opioid actions Neuropeptides 11 1988 173 180
8. R.A. North Drug receptors and the inhibition of nerve cells Br J Pharmacol 98 1989 13 28
9. S. Arner B.A. Meyerson Lack of analgesic effect of opiates on neuropathic and idiopathic forms of pain Pain 33 1988 11 23
10. R.K. Portenoy K.M. Foley C.E. Inturrisi The nature of opioid responsiveness and its implications for neuropathic pain New hypotheses derived from studies of opioid infusions Pain 43 1990 273 286
11. A.R. Jadad D. Carroll C.J. Glynn R.A. Moore H.J. McQuay Morphine responsiveness of chronic pain Double-blind randomised crossover study with patient-controlled analgesia Lancet 339 1992 1367 1371
12. J.E. Haley A.F. Sullivan A.H. Dickenson Evidence for spinal N -methyl- d -aspartate receptor involvement in prolonged chemical nociception in the rat Brain Res 518 1990 218 226
13. A.H. Dickenson A.F. Sullivan Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation Neuropharmacology 26 1987 1235 1238
14. T.J. Coderre I. Van Empel The utility of excitatory amino acid antagonists as analgesic agents. II. Assessment of antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric glycine and polyamine receptor sites Pain 59 1994 353 360
15. T.J. Coderre I. Van Empel The utility of excitatory amino acid antagonists as analgesic agents. I. Comparison of antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests Pain 59 1994 345 352
16. T.J. Coderre J. Katz A.L. Vaccarino R. Meezack Contribution of central neuroplasticity to pathological pain Review of clinical and experimental evidence Pain 52 1993 259 285
17. E.H.F. Wong J.A. Kemp T. Priestly A.R. Knight G.N. Woodruff L.L. Iversen The anticonvulsant MK-801 is a potent N -methyl- d -aspartate antagonist Proc Natl Acad Sci USA 83 1986 7104 7108
18. J. Mao D.D. Price D.J. Mayer J. Lu R.L. Hayes Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviours in rats with experimental peripheral mononeuropathy Brain Res 576 1992 254 262
19. J.W. Olney J. Labruyere M.T. Price Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs Science 244 1989 1360 1362
20. F.C. Tortella M. Pellicano N.G. Bowery Dextromethorphan and neuromodulation Old drug coughs up new activities Trends Pharmacol Sci 10 1989 501 507
21. E.D. Kharasch R. Labroo Metabolism of ketamine stereoisomers by human liver microsomes Anesthesiology 77 1992 1201 1207
22. I.S. Grant W.S. Nimmo J.A. Clements Pharmacokinetics and analgesic effects of i.m. and oral ketamine Br J Anaesth 53 1981 805 810
23. D. Martin D. Lodge Ketamine acts as a noncompetitive N -methyl- d -aspartate antagonist on frog spinal cord in vitro Neuropharmacology 10 1985 999 1003
24. D.L. Reich G. Silvay Ketamine An update on the first twenty-five years of clinical experience Can J Anaesth 36 1989 186 197
25. B. Ebert S. Mikkelsen C. Thorkildsen F.M. Borgbjerg Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord Eur J Pharmacol 333 1997 99 104
26. B. Ebert E.H.F. Wong P. Krogsgaard-Larsen Identification of a novel NMDA receptor in rat cerebellum Eur J Pharmacol Mol Pharmacol 208 1991 49 52
27. H.J. McQuay D. Carroll A.R. Jadad C.J. Glynn T. Jack R.A. Moore P.J. Wiffeh Dextromethorphan for the treatment of neuropathic pain A double-blind randomised controlled crossover trial with integral n-of-1 design Pain 59 1994 127 133
28. D.D. Price J. Mao H. Frenk D.J. Mayer The N -methyl- d -aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man Pain 59 1994 165 174
29. K. Elliot A. Hynansky C.E. Inturrisi Dextromethorphan attenuates and reverses analgesic tolerance to morphine Pain 59 1994 361 368
30. K. Ren Wind-up and the NMDA receptor From animal studies to humans Pain 59 1994 157 158
31. V. Chapman A.H. Dickenson The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn Brain Res 573 1992 321 323
32. P.V. Petersen Studies on a new spasmolytic compound 1,1-diphenyl-3-demethylaminobutene-1 (A29) and a potent analgesic, ketobemidone (A21) Acta Pharmacol Toxicol 7 1951 51 64
33. N.L. Harrison M.A. Simmonds Quantitative studies on some antagonists of N -methyl- d -aspartate in slices of rat cerebral cortex Br J Pharmacol 84 1985 381 391
34. P.L. Wheatley A simple method for recording excitatory amino acid evoked depolarizations of rat cortex in vitro Br J Pharmacol 87 1986 159P
35. B. Ebert S. Andersen P. Krogsgaard-Larsen Ketobemidone, methadone and pethidine are noncompetitive NMDA antagonists in the rat cortex and spinal cord Neurosci Lett 187 1995 165 168
36. C.B. Christensen The opioid receptor binding profile of ketobemidone and morphine Pharmacol Toxicol 73 1993 344 345
37. S. Andersen A.H. Dickenson M. Kohn A. Reeve W. Rahman B. Ebert The opioid ketobemidone has a NMDA blocking effect Pain 67 1996 369 374
38. P. Anderson S. Arnér U. Bondesson L.O. Boréus P. Hartvig Single-dose kinetics and bioavailability of ketobemidone Acta Anaesthesiol Scand Suppl 74 1982 59 62
39. O. Husveith A. Maurset I. Øye Interaction of chiral forms of ketamine with opioid, phencyclidine, σ and muscarinic receptors Pharmacol Toxicol 77 1995 355 359
40. H. Hall S.O. Ogren Effects of antidepressant drugs on different receptors in the brain Eur J Pharmacol 70 1981 393 407
41. I.J. Reynolds R.J. Miller Tricyclic antidepressants block N -methyl- d -aspartate receptors Similarities to the action of zinc Br J Pharmacol 95 1988 95 102
42. J.C. Eisenach G.F. Gebhart Intrathecal amitriptyline acts as an N -methyl- d -aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats Anesthesiology 83 1995 1046 1054
43. P. Onghena B. Van Houdenhove Antidepressant-induced analgesia in chronic non-maligant pain A meta-analysis of 39 placebo-controlled studies Pain 49 1992 205 219
44. J.J. Larsen A.V. Christensen The antinociceptive effect of ketobemidone in comparison with Ketogin® Acta Pharmacol Toxicol 52 1983 100 104
45. B. Ebert C. Thorkildsen S. Andersen Ketobemidone plus ( RS )-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone; evidence for A29 as a noncompetitive NMDA receptor antagonist Pharmacol Toxicol 82 1998 157 160
46. 2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine Life Sci 56 1994 L45 PL50
47. A.L. Gorman K.J. Elliott C.E. Inturrisi The d - and l -isomers of methadone bind to the noncompetitive site on the N -methyl- d -aspartate (NMDA) receptor in rat forebrain and spinal cord Neurosci Lett 223 1997 5 8
48. E.J. Bilsky C.E. Inturrisi W. Sadée V.J. Hruby F. Porreca Competitive and noncompetitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice Pain 68 1996 229 237
49. A.H. Beckett J.F. Taylor A.F. Casy M.M. Hassan The biotransformation of methadone in man Synthesis and identification of a major metabolite Pharm Pharmacol 20 1968 754 762
50. B. Ebert S. Andersen H. Hjeds A.H. Dickenson Dextropropoxyphene acts as a noncompetitive NMDA antagonist Pain Symptom Management 15 1998 269 274
51. T.A. Lyle C.A. Magill S.F. Britcher G.H. Denny W.J. Thompson J.S. Murphy A.R. Knight J.A. Kemp G.R. Marshall D.N. Middlemiss E.H.F. Wong P.S. Anderson Structure and activity of hydrogenated derivatives (+)-5-methyl-10,11-dihydro-5 H -dibenzo[ a , d ]cyclohepten-5,10-imine (MK-801) J Med Chem 33 1990 1047 1052
52. W.J. Thompson P.S. Anderson S.F. Britcher T.A. Lyle J.E. Thies C.A. Magill S.L. Varga J.E. Schwering P.A. Lyle M.E. Christy B.E. Evans M.D. Colton M.K. Holloway J.P. Springer J.M. Hirshfield R.G. Ball J.S. Amato R.D. Larsen E.H.F. Wong J.A. Kemp M.D. Tricklebank L. Singh R. Oles T. Priestly G.R. Marshall A.R. Knight D.N. Middlemiss G.N. Woodruff L.L. Iversen Synthesis and pharmacological evaluation of a series of dibenzo[ a , d ]cycloalkenimines as N -methyl- d -aspartate antagonists J Med Chem 33 1990 789 808
53. D.W. Choi V. Viseskul Opioids and non-opioid enantiomers selectively attenuate N -methyl- d -aspartate neurotoxicity in cortical neurones Eur J Pharmacol 155 1988 27 35